Allied Health & Imaging · Independent exam preparation
Geriatric Medicine Certification Examination Study Guide
Study geriatric diagnosis, safer prescribing, functional assessment, prevention, and goals-of-care decisions through 60 focused concepts, 20 explained clinical questions, and 20 flashcards.
By CertMedbry · Updated 29 October 2026
Learn to distinguish acute illness from chronic impairment, reduce treatment-related harm, interpret functional change, and align care with an older adult's goals. These 60 selective concepts span all six domains of the August 2026 ABIM certification blueprint. Their distribution approximates the published domain weights, but individual topics are selected examples. The complete official outline defines the full examination scope, including topics beyond this guide.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and certification pathway does this guide address?
The official name is the Geriatric Medicine Certification Examination. This guide follows the ABIM physician subspecialty pathway. ABIM and the American Board of Family Medicine jointly develop the certification program, while ABIM administers this examination. ABFM has its own certification pathway. The label “ABIM - Subspecialty in Geriatric Medicine” identifies this examination rather than a separate current examination.
ABIM Geriatric Medicine Certification Policies · Register, Prepare and Take Your Subspecialty Certification Exam — Geriatric Medicine
How many questions are included, and which questions count toward the score?
The August 2026 certification blueprint describes up to 240 single-best-answer multiple-choice questions. Approximately 40 are new questions that do not count toward the score. These figures should not be interpreted as a guaranteed exact number of scored questions on every administration.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
What question styles and clinical material should candidates expect?
Most questions describe patient scenarios. Tasks include diagnosis, test selection and interpretation, treatment, prognosis, epidemiologic reasoning, and applied pathophysiology. Clinical material may include photographs, radiographs, electrocardiograms, heart-sound recordings, video, and other media. The questions in this guide are independent four-option learning exercises.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
How is the examination organized?
The examination information page describes four sessions with up to 60 multiple-choice questions each. Consult ABIM's examination information and candidate instructions for current appointment arrangements, session timing, breaks, and test-day requirements.
Register, Prepare and Take Your Subspecialty Certification Exam — Geriatric Medicine
Which blueprint applies, and when does the expanded blueprint begin?
This guide uses the current linked Certification Examination blueprint dated August 2026. The PDF states no separate effective date. ABIM's rollout schedule places Geriatric Medicine expanded-blueprint publication in January 2028 and certification-examination implementation in fall 2028. That future outline does not replace the current outline for this guide. Certification and maintenance-of-certification blueprints have separate links.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026 · ABIM Blueprints · ABIM Expanded Blueprints
How are the official domains weighted?
The blueprint assigns Gerontology 5%; Diseases in the Elderly 45%; Geriatric Psychiatry 8.5%; Geriatric Syndromes 22.5%; Functional Assessment and Rehabilitation 3%; and Caring for Elderly Patients 16%. This guide allocates its 60 concepts as 3, 27, 5, 14, 2, and 9 respectively. The questions and flashcards each allocate 1, 9, 2, 4, 1, and 3. These distributions approximate the official weights without implying complete topic coverage.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
This independent educational guide concerns the physician subspecialty pathway administered by ABIM. Its original practice questions assess clinical reasoning and do not reproduce official examination content or predict certification results.
Outline used: Current linked ABIM Certification Examination (CERT) blueprint, dated August 2026, verified on 2026-10-11. No separate effective date is stated in the PDF. The workbook label 'ABIM - Subspecialty in Geriatric Medicine' maps to the official Geriatric Medicine Certification Examination; the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Gerontology5%
1.How does reduced renal reserve change medication risk?
Aging can reduce renal drug elimination, while lower muscle mass can make serum creatinine appear reassuring despite impaired kidney function. Medication safety therefore depends on estimated renal function, the drug's clearance pathway, and the patient's observed response. Declining kidney function can prolong insulin action and increase hypoglycemia risk. A new adverse effect after illness should trigger reassessment of physiology and treatment burden rather than automatic attribution to chronological age.
Apply it
An older adult resumes a previously tolerated insulin regimen after an illness associated with declining kidney function and develops overnight hypoglycemia. Reassess renal function, food intake, actual administration, and treatment intensity.
Common pitfall: A serum creatinine within the laboratory reference range does not establish normal drug clearance. Age alone also does not justify stopping every renally cleared medication.
2.How do absolute effects clarify treatment benefit?
Relative risk reduction describes proportional change, whereas absolute risk reduction describes the difference in event probabilities between groups. The number needed to treat is the reciprocal of absolute risk reduction expressed as a proportion. These quantities require a stated outcome and follow-up interval. An impressive relative reduction may represent a small absolute benefit when baseline risk is low, so decisions should connect the estimate to the patient's underlying risk.
Apply it
In a hypothetical three-year trial, fractures occur in 12% of controls and 8% of treated participants. The absolute reduction is four percentage points, giving a number needed to treat of 25 over three years.
Common pitfall: Using percentages as whole numbers produces an incorrect reciprocal. A number needed to treat without its outcome and time horizon is incomplete.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
3.When can trial findings inform an individual older adult's care?
A valid trial estimate does not establish the same net benefit for every patient. Applicability depends on participant characteristics, baseline risk, intervention delivery, outcomes, follow-up, and competing burdens. Frailty, multimorbidity, and difficulty following a regimen can alter the practical balance. Distinguish uncertainty about whether treatment works from uncertainty about how much its effects matter for this patient, considering both desirable and undesirable outcomes.
Apply it
A trial shows fewer events after five years in independent participants. Your patient has substantial functional dependence and prioritizes reducing daily treatment burden. Compare population, time horizon, and harms before recommending the same regimen.
Common pitfall: Statistical significance does not establish clinical importance or individual applicability. Exclusion from a trial population also does not prove that treatment cannot help.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
Diseases in the Elderly45%
4.How should orthostatic blood pressure be measured?
The CDC STEADI protocol begins with five minutes lying down, followed by blood pressure and pulse measurements. Repeat measurements after standing for one minute and three minutes, and ask about symptoms. A systolic decrease of at least 20 mm Hg, a diastolic decrease of at least 10 mm Hg, or light-headedness or dizziness is abnormal in this screening protocol. Measuring the positional change is more informative than comparing unrelated office readings.
Apply it
After five minutes supine, a patient's pressure is 146/78 mm Hg. At one minute standing it is 122/72, with light-headedness. The systolic decrease is 24 mm Hg; document the abnormal result and complete the assessment safely.
Common pitfall: A seated pressure alone cannot establish the supine-to-standing response. Symptoms remain relevant even when a particular measurement does not reach the numerical threshold.
5.Why should postural symptoms prompt a medication and volume review?
Standing shifts blood toward the lower body, requiring compensatory vascular and cardiac responses to preserve cerebral perfusion. Volume depletion and pressure-lowering medicines can worsen the response. A reproducible relationship between standing and symptoms directs attention toward orthostatic physiology, while the broader assessment considers competing causes. Management should connect the measured abnormality to reversible contributors and fall risk rather than respond only to an elevated supine pressure.
Apply it
Morning light-headedness begins after a diuretic change and several days of poor intake. Obtain standardized orthostatic measurements, assess hydration and medication exposure, and address contributors while preventing another fall.
Common pitfall: An elevated supine reading can distract from symptomatic standing hypotension. Reducing every cardiovascular medicine without reviewing its indication may create another preventable harm.
CDC STEADI: Measuring Orthostatic Blood Pressure · CDC STEADI Algorithm for Fall Risk Screening, Assessment, and Intervention
6.How should stroke risk, bleeding risk, and dose criteria guide atrial fibrillation anticoagulation?
Atrial fibrillation promotes atrial blood stasis and thromboembolism. When stroke risk warrants anticoagulation, aspirin or aspirin plus clopidogrel is not an equivalent substitute. Previous stroke or TIA adds two CHA2DS2-VASc points. Bleeding scores should identify modifiable hazards rather than independently veto treatment; review unnecessary antiplatelets, NSAIDs, interactions, renal function, and prior bleeding. Use agent-specific dose criteria. For apixaban in atrial fibrillation, reduction to 2.5 mg twice daily generally requires at least two of age at least 80 years, weight at most 60 kg, and serum creatinine at least 1.5 mg/dL.
Apply it
An 82-year-old with previous stroke, weight 74 kg, creatinine 0.9 mg/dL, and no relevant valve exclusion needs an anticoagulation discussion. Age alone does not meet the usual apixaban reduction rule. Remove aspirin if it lacks a separate indication.
Common pitfall: A high bleeding score can coexist with substantial stroke-prevention benefit. Empiric underdosing may compromise protection, while continuing unnecessary aspirin increases avoidable bleeding exposure.
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
7.Which valve conditions change anticoagulant selection in atrial fibrillation?
Direct oral anticoagulants are generally preferred over warfarin in eligible patients with atrial fibrillation, but important valve exceptions apply. Warfarin is recommended for atrial fibrillation with rheumatic mitral stenosis or mitral stenosis of moderate or greater severity. Mechanical heart valves also require a vitamin K antagonist rather than a direct oral anticoagulant. A precise valve history and echocardiographic description matter more than the vague label of valvular heart disease.
Apply it
A patient requests a switch from warfarin to a direct oral anticoagulant. Echocardiography documents moderate mitral stenosis. Explain why the valve finding changes the usual drug preference.
Common pitfall: Do not treat every valve abnormality as a direct oral anticoagulant exclusion. Conversely, omitting nonrheumatic mitral stenosis of moderate or greater severity misses a relevant boundary.
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
8.How do congestion treatment and disease-modifying therapy differ in heart failure?
In heart failure with reduced ejection fraction, foundational therapy includes an ARNI, or ACE inhibitor or ARB when appropriate; an evidence-based beta blocker; a mineralocorticoid receptor antagonist; and an SGLT2 inhibitor. SGLT2 benefit does not require diabetes. Loop diuretics relieve fluid retention but do not replace these treatments. Assess congestion, blood pressure, renal function, potassium, and treatment tolerance. Initiating an MRA generally requires eGFR above 30 mL/min/1.73 m² and potassium below 5.0 mEq/L, with subsequent monitoring. These distinctions follow the [AHA/ACC/HFSA heart failure guideline](https://www.jacc.org/doi/10.1016/j.jacc.2021.12.011).
Apply it
A stable older adult with LVEF 30% improves after diuresis but takes only furosemide. Review eligibility for foundational therapy rather than interpreting relief of edema as completion of treatment.
Common pitfall: Escalating diuresis in an already euvolemic patient can worsen postural symptoms and kidney function. Improvement in ejection fraction also does not automatically justify stopping established HFrEF therapy.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
9.When does a fragility fracture justify osteoporosis treatment?
A hip or vertebral fracture supports pharmacologic osteoporosis treatment regardless of bone mineral density. Bone density remains useful for characterization and follow-up, but treatment eligibility after these fractures does not depend on crossing a densitometric threshold. The fracture is a clinical risk event. Evaluation should also address contributing conditions, nutrition, fall risk, and the feasibility of sustained treatment.
Apply it
An older adult sustains a hip fracture after falling from standing height. A previous DXA showed osteopenia. Arrange secondary fracture prevention rather than withholding treatment because the earlier T-score was above -2.5.
Common pitfall: A nonosteoporotic T-score does not erase the significance of a hip or vertebral fracture. Do not generalize this rule indiscriminately to every fracture site.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022
10.Why does stopping denosumab require a treatment plan?
Denosumab suppresses bone resorption, but its effect reverses after discontinuation. Stopping can cause rapid bone loss and increased vertebral fracture risk, so an intentional transition to another antiresorptive treatment is needed. Before discontinuing or allowing repeated delays, establish why treatment is changing and how skeletal protection will continue, accounting for contraindications and access to the next therapy.
Apply it
A patient wants to stop denosumab after moving clinics. Reconcile the last administration date and arrange an appropriate antiresorptive transition with the receiving clinician, including clear responsibility for follow-up.
Common pitfall: Applying a bisphosphonate holiday concept to denosumab overlooks its reversibility. Administrative interruption can have clinical consequences even when the patient feels well.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022
11.How does stroke mechanism determine secondary antithrombotic treatment?
After noncardioembolic ischemic stroke or TIA, use antiplatelet therapy rather than routine anticoagulation. Long-term options include aspirin, clopidogrel, or aspirin with extended-release dipyridamole. Selected patients presenting early with minor noncardioembolic stroke, NIHSS at most 3, or high-risk TIA, ABCD2 at least 4, qualify for short-term aspirin plus clopidogrel for 21–90 days, followed by single therapy. Continuous aspirin plus clopidogrel beyond 90 days increases hemorrhage risk. Establish the mechanism and control vascular risk factors. See the [AHA/ASA secondary prevention guideline](https://doi.org/10.1161/STR.0000000000000375).
Apply it
A patient is seen four months after a noncardioembolic minor stroke and remains on aspirin plus clopidogrel without another indication. Reassess the intended duration and transition to appropriate single antiplatelet therapy.
Common pitfall: Short-term dual therapy is not indicated after every stroke. Atrial fibrillation, specific arterial lesions, and other identified mechanisms can change the antithrombotic plan.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
12.How can a swallowing problem change a neurologic care plan?
Dysphagia can compromise hydration, nutrition, medication delivery, and airway protection. Coughing with meals, a wet voice after swallowing, prolonged meals, or recurrent respiratory illness should prompt swallowing assessment. The cause and expected course matter: a new swallowing deficit after a neurologic event differs from progressive eating difficulty in advanced dementia. Establish safe intake and an appropriate medication route while evaluating reversibility and the patient's goals.
Apply it
After a new neurologic illness, a patient coughs when drinking water and cannot reliably swallow tablets. Request swallowing assessment and review oral medication administration before simply resuming the preillness diet.
Common pitfall: A feeding tube does not eliminate aspiration of saliva or refluxed material. Advanced-dementia feeding evidence should not automatically determine management of a potentially reversible swallowing disorder.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026 · American Geriatrics Society Feeding Tubes in Advanced Dementia Position Statement — publisher full text, 2014
13.When should recurrent hypoglycemia trigger diabetes deintensification?
Severe or recurrent hypoglycemia warrants reassessment and deintensification of hypoglycemia-causing treatment, even when A1C appears acceptable. An average glucose measure can conceal dangerous lows and wide excursions. Review insulin and other relevant medicines, renal function, meal consistency, cognition, and assistance. Reduce preventable harm while retaining an individualized plan that avoids symptomatic hyperglycemia and remains feasible.
Apply it
An older adult with A1C 6.7% has two episodes requiring family assistance. Review and reduce hypoglycemia-producing treatment rather than praising the A1C, while checking meals, kidney function, and administration.
Common pitfall: A favorable A1C does not make recurrent hypoglycemia acceptable. Deintensification does not mean abandoning monitoring or allowing persistent symptomatic hyperglycemia.
14.How does insulin simplification differ from merely lowering a dose?
Dose reduction changes treatment intensity, whereas simplification reduces the number or complexity of tasks required to deliver treatment. A patient may be unable to calculate variable doses, coordinate injections with meals, or manage frequent checks despite needing glucose-lowering therapy. Simplification matches the regimen to functional ability and available support. Repeated management difficulty or burden is a key cue even without an unusually low A1C.
Apply it
A patient can administer one consistent injection but repeatedly confuses a multi-injection schedule and correction calculations. Reassess regimen structure and support rather than only reducing each existing dose.
Common pitfall: Lower doses do not solve a calculation or scheduling problem. A simpler regimen still needs individualized monitoring, education, and reassessment.
13. Older Adults: Standards of Care in Diabetes—2026 · ADA: Insulin Deintensification in Type 2 Diabetes
15.How does the ADA health-status framework guide glycemic goals?
Healthy older adults with few coexisting chronic illnesses and intact cognition and function may reasonably target A1C below 7.0-7.5%. Complex/intermediate health, including multiple chronic illnesses, mild-to-moderate cognitive impairment, or instrumental functional limitations, commonly supports a target below 8.0%. Very complex/poor health, including end-stage illness, moderate-to-severe cognitive impairment, or substantial basic ADL dependence, calls for avoiding reliance on A1C and prioritizing prevention of hypoglycemia and symptomatic hyperglycemia. Individualize these goals to preferences, burden, and safety.
Apply it
A patient with several chronic illnesses, mild cognitive impairment, and help with medicines fits the complex/intermediate category. A target below 8.0% may be reasonable, with recurrent hypoglycemia still requiring treatment reassessment.
Common pitfall: These categories guide judgment rather than impose age-based targets. A lower A1C is reasonable only when achievable without recurrent hypoglycemia or undue burden.
16.Why should kidney assessment include both filtration and albuminuria?
Estimated glomerular filtration rate describes filtration, while urine albumin-to-creatinine ratio identifies albumin leakage and contributes independent prognostic information. Albuminuria can precede a major fall in filtration. Chronic kidney disease requires persistent kidney abnormalities for at least three months; an isolated abnormal result during acute illness does not establish chronicity. In diabetes, assess both measures to characterize kidney risk and guide treatment rather than relying on serum creatinine alone.
Apply it
A patient with diabetes has preserved estimated filtration but repeatedly elevated urine albumin-to-creatinine ratios over more than three months. Recognize kidney disease despite an apparently reassuring filtration value.
Common pitfall: A single elevated urine albumin result may be transient. Conversely, low estimated filtration can occur without albuminuria, so either measure alone provides an incomplete assessment.
ADA Standards of Care in Diabetes · 13. Older Adults: Standards of Care in Diabetes—2026
17.When should bacteriuria be treated in an older adult?
Bacteriuria, even with pyuria, does not establish symptomatic urinary infection. In delirium or a fall without local genitourinary symptoms, fever, or hemodynamic instability, assess other causes and observe rather than treating the urine result. Long-term catheter colonization also usually remains untreated when asymptomatic. An important exception is an endoscopic urologic procedure expected to cause mucosal trauma, for which screening and targeted antimicrobial treatment are recommended.
Apply it
A stable resident becomes inattentive after poor intake and a sedating medicine. A positive culture without urinary or systemic infection signs should not displace evaluation of those contributors. Before transurethral surgery involving mucosal trauma, the same asymptomatic finding changes peri-procedural management.
Common pitfall: Do not extend observation-only management to a patient with possible sepsis. The procedural exception also does not justify treatment before every catheter change or unrelated operation.
IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
18.When should anemia and bone symptoms raise concern for myeloma?
Vertebral fracture or bone pain accompanied by unexplained anemia, renal dysfunction, or hypercalcemia should prompt evaluation for a secondary skeletal disorder, including a plasma-cell malignancy. The osteoporosis evaluation includes a blood count and biochemical assessment; selected findings justify serum protein studies and serum free light chains. A low bone-density result does not establish that ordinary osteoporosis explains every fracture or laboratory abnormality.
Apply it
A patient with a new vertebral compression fracture also has progressive anemia and worsening renal function. Investigate the combined pattern rather than prescribing osteoporosis treatment and attributing the other findings to age.
Common pitfall: Anemia alone does not diagnose myeloma, and a monoclonal protein alone does not establish symptomatic malignancy. The clinical pattern determines the need for further hematologic assessment.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022
19.How should gastrointestinal bleeding affect an anticoagulation plan?
Major gastrointestinal bleeding requires stabilization, assessment of the bleeding source, and review of anticoagulant exposure and contributing medicines. Correct reversible causes, including unnecessary antiplatelets or NSAIDs. After bleeding is controlled, resuming anticoagulation may be reasonable when thromboembolic benefit outweighs recurrent bleeding risk. The decision should integrate the cause and treatability of bleeding, stroke risk, and patient preferences rather than treating every gastrointestinal bleed as a permanent contraindication.
Apply it
An anticoagulated patient with atrial fibrillation has a gastrointestinal bleed while also taking an unnecessary NSAID. After source treatment and stabilization, reassess anticoagulation with the avoidable exposure removed.
Common pitfall: Continuing treatment unchanged during uncontrolled major bleeding is unsafe. Permanent discontinuation without reassessing a corrected bleeding cause can also leave substantial preventable stroke risk.
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
20.How can intestinal disease present through skeletal fragility?
Malabsorption can reduce calcium and vitamin D availability and contribute to secondary skeletal disease. Celiac disease is one consideration when low bone density or fragility fractures coexist with suggestive nutritional abnormalities or gastrointestinal features. The BHOF evaluation includes selected testing for tissue transglutaminase antibodies when clinically indicated. Evaluate the pattern rather than assuming every older adult's low bone density is solely age-related.
Apply it
A patient with fragility fractures also has persistent nutrient deficiencies and chronic loose stools. Assess for malabsorption and an underlying intestinal disorder alongside fracture prevention.
Common pitfall: Universal testing for every possible secondary cause is unnecessary. Conversely, absent dramatic gastrointestinal symptoms does not by itself exclude an intestinal contribution to skeletal disease.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022
21.Who should be tested for Clostridioides difficile infection?
The preferred testing population has unexplained, new-onset diarrhea with at least three unformed stools in 24 hours. Consider alternative explanations such as laxatives before interpreting a positive result. Testing without a compatible syndrome can detect colonization and lead to unnecessary treatment. Specimen selection and the testing algorithm affect interpretation, so the clinical indication remains essential.
Apply it
A patient develops four unformed stools in a day after antibiotic exposure, without laxatives or another clear explanation. Test in the context of the diarrheal syndrome rather than screening an asymptomatic roommate.
Common pitfall: Antibiotic exposure alone is not a testing indication. Formed stools or resolved symptoms generally do not provide the compatible clinical setting needed to interpret infection testing.
SHEA/IDSA 2017 Clinical Practice Guideline Update for Clostridium difficile Infection
22.Why can ACE inhibitors or ARBs cause hyperkalemia in kidney disease?
Renin-angiotensin system blockade reduces aldosterone-mediated potassium excretion. Reduced kidney function, acute illness, potassium supplements, and other potassium-retaining medicines can increase the risk. Monitor potassium and kidney function after initiation or dose escalation and when the clinical state changes. Mild laboratory changes require interpretation in context; severe hyperkalemia or an acute deterioration requires prompt assessment rather than routine follow-up.
Apply it
A patient with diabetic kidney disease develops hyperkalemia after an ARB dose increase while using a potassium-containing salt substitute. Review kidney function, supplements, diet, and concurrent medicines before deciding how to modify treatment.
Common pitfall: A beneficial kidney-protective indication does not eliminate monitoring needs. An unexpected potassium result should also be assessed for specimen-related error without delaying care when the clinical risk is high.
23.How should an initial C. difficile episode be classified, treated, and followed?
IDSA/SHEA laboratory criteria classify nonsevere disease as WBC at most 15,000/µL and serum creatinine below 1.5 mg/dL. Severe disease has WBC above 15,000/µL or creatinine at least 1.5 mg/dL. Hypotension or shock, ileus, or megacolon indicates fulminant disease. For an initial nonfulminant episode, the 2021 update suggests fidaxomicin 200 mg orally twice daily for 10 days; vancomycin 125 mg orally four times daily for 10 days remains an acceptable alternative, including when fidaxomicin is inaccessible. Assess response clinically and avoid routine tests of cure because positivity can persist after recovery.
Apply it
A patient with WBC 12,000/µL, creatinine 1.0 mg/dL, and no fulminant features has nonsevere disease. If fidaxomicin is unaffordable, prescribe oral vancomycin 125 mg four times daily for 10 days and follow symptoms.
Common pitfall: Advanced age alone does not establish severe or fulminant disease. The creatinine threshold is at least 1.5 mg/dL, and these laboratory criteria require caution in patients with underlying renal dysfunction. Fulminant disease requires a different treatment strategy.
SHEA/IDSA 2021 Focused Update for Clostridioides difficile Infection · SHEA/IDSA 2017 Clinical Practice Guideline Update for Clostridium difficile Infection
24.Why is exercise foundational in osteoarthritis care?
Exercise improves pain and function in osteoarthritis and is strongly recommended. Tailor activity to symptoms, abilities, preferences, and access. Strengthening and other suitable activity address limitations that analgesics alone do not resolve. A sustainable plan anticipates initial difficulty and adjusts the activity rather than abandoning movement whenever discomfort appears.
Apply it
A patient with knee osteoarthritis stops walking because activity hurts and becomes less able to rise from a chair. Develop a tolerable exercise program alongside symptom treatment, and assess improvement in transfers and walking.
Common pitfall: Temporary symptom modification differs from prolonged inactivity. Exercise advice must still account for acute injury, unusual findings, and actual functional capacity rather than assuming all pain is established osteoarthritis.
2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
25.How does joint location affect topical NSAID selection?
Topical NSAIDs are strongly recommended for knee osteoarthritis and should be considered before oral NSAIDs because local treatment generally produces less systemic exposure. The recommendation does not transfer directly to hip osteoarthritis: the hip lies much deeper beneath the skin. Confirm the pain source and relevant anatomy, then consider skin condition, concurrent medicines, and the ability to apply treatment.
Apply it
For localized knee osteoarthritis, consider a topical NSAID alongside exercise. For deep groin pain attributed to hip osteoarthritis, develop a hip-specific plan rather than assuming a knee gel provides equivalent treatment.
Common pitfall: Topical treatment is not free of systemic absorption or adverse effects. A shared osteoarthritis diagnosis does not eliminate anatomical differences between joints.
2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
26.How does kidney dysfunction complicate osteoporosis drug selection?
Bisphosphonates have agent-specific renal restrictions, generally around estimated filtration or creatinine clearance of 30–35 mL/min. Denosumab is not a risk-free substitute: its FDA boxed warning identifies severe, sometimes fatal hypocalcemia in advanced CKD, particularly with dialysis or CKD–mineral and bone disorder. Assess kidney function, serum calcium, and evidence of CKD–mineral and bone disorder. If denosumab is chosen, involve a clinician experienced in CKD-related bone disease, manage that disorder, correct hypocalcemia, and provide appropriate calcium and activated vitamin D before and during treatment. Monitor calcium closely afterward, especially during weeks 2–10, with greatest risk during weeks 2–5.
Apply it
A dialysis patient with a fragility fracture and low calcium needs evaluation for CKD-related bone disease and expert treatment selection. If denosumab remains appropriate, establish supplementation, correction of biochemical abnormalities, and a specific post-dose calcium-monitoring plan before administration.
Common pitfall: Lack of renal dose adjustment does not establish denosumab safety in advanced CKD. Separately, do not stop, skip, or delay established denosumab without a planned transition because rebound bone loss and vertebral fractures can follow.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022 · FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) | FDA
27.Which oxygen measurements establish severe chronic resting hypoxemia?
ATS criteria are stable room-air PaO2 at or below 55 mm Hg or SpO2 at or below 88%; alternatively, PaO2 56-59 mm Hg or SpO2 89% with edema, hematocrit at least 55%, or P pulmonale on ECG. Chronic hypoxemia persists without a reversible cause. For qualifying COPD, prescribe long-term oxygen for at least 15 hours daily. COPD with moderate resting SpO2 89-93% generally does not warrant routine long-term oxygen. Severe exertional desaturation, commonly SpO2 at or below 88% during exertion, supports a separate conditional ambulatory-oxygen decision.
Apply it
A stable patient with COPD repeatedly has resting room-air SpO2 87% without an acute reversible cause and meets the severe-resting criterion. Another patient resting at 92% but falling to 87% during walking requires an exertional-oxygen assessment.
Common pitfall: Breathlessness alone does not establish eligibility. Oxygen prescribed during an exacerbation requires reassessment because the hypoxemia may resolve.
28.What safety education belongs with home oxygen?
ATS recommends patient and caregiver instruction in oxygen equipment use, maintenance, and safety. Oxygen supports combustion, creating serious hazards around smoking, flames, and ignition sources. Tubing introduces mobility and tripping risks. Establish that the household can operate the system safely and manage the actual living environment rather than merely providing a handout.
Apply it
A patient starting oxygen has a household member who smokes indoors and long tubing across a narrow hallway. Address fire exposure, tubing placement, equipment operation, and maintenance with both patient and caregiver.
Common pitfall: Oxygen itself is not flammable, but it accelerates combustion. Familiarity with equipment does not establish safe household use; ask the patient or caregiver to demonstrate practical understanding.
29.Which macular symptoms require prompt assessment?
Age-related macular degeneration damages central vision. Dry disease involves progressive macular damage and thinning; wet disease involves abnormal vessels that leak blood or fluid beneath the retina and can progress rapidly. New straight lines appearing wavy, central distortion, or a rapid change in central vision warrants prompt eye assessment. Preserved peripheral navigation does not establish adequate reading or medication-label vision.
Apply it
A patient with known dry disease notices bent doorframes and distorted print over several days. Arrange prompt eye assessment and immediate help with medication labels rather than waiting for routine refraction.
Common pitfall: A prior dry diagnosis does not guarantee that subsequent disease remains dry. Independent walking can coexist with serious central visual impairment.
30.When can A1C misrepresent glycemia in kidney disease or anemia?
A1C depends on both glucose exposure and red-cell lifespan. Advanced kidney disease, erythropoietin treatment, recent blood loss, transfusion, or other changes in red-cell turnover can make it misleading. Shortened red-cell survival may lower A1C despite clinically important hyperglycemia. When A1C and observed glucose disagree, use glucose monitoring or continuous glucose data to guide decisions rather than intensifying or relaxing treatment from A1C alone.
Apply it
A patient receiving dialysis and erythropoietin has a low A1C but repeatedly high measured glucose. Recognize altered red-cell turnover and assess actual glucose patterns before changing treatment.
Common pitfall: A1C discordance is not automatically poor adherence or inaccurate reporting. The direction of error varies with the underlying red-cell disorder.
Geriatric Psychiatry8.5%
31.What establishes a major depressive episode, and when is major depressive disorder appropriate?
A major depressive episode requires at least five of nine symptom categories during the same two weeks, representing a change from previous functioning. At least one must be depressed mood or markedly diminished interest or pleasure, present most of the day, nearly every day. Other categories are significant weight loss without dieting or weight gain, or appetite change nearly every day; insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day, observable by others; fatigue nearly every day; worthlessness or excessive or inappropriate guilt nearly every day; impaired concentration or indecisiveness nearly every day; and recurrent death thoughts, recurrent suicidal ideation, a suicide attempt, or a specific suicide plan. Significant weight change and recurrent death or suicidal thoughts have distinct criteria and should not be forced into a daily-symptom rule. Require significant distress or impairment and exclude substance or medical causation. Before diagnosing major depressive disorder, assess mania or hypomania and psychotic-disorder explanations. See [SAMHSA's diagnostic criteria exhibit](https://www.ncbi.nlm.nih.gov/books/NBK571021/box/ch4.b4/?report=objectonly).
Apply it
For three weeks, a patient has anhedonia most of the day nearly every day, nearly daily insomnia, low energy, impaired concentration, and excessive guilt, with decline from baseline and functional impairment. Assess medical and medication contributors, bipolar history, psychotic symptoms, and suicide risk.
Common pitfall: Five transient symptoms occurring somewhere within two weeks do not establish an episode. Subjectively feeling slowed is insufficient for the psychomotor criterion without observable change. Anhedonia can satisfy the core requirement when sadness is absent.
32.When does persistent worry suggest generalized anxiety disorder, and how should it be treated?
Generalized anxiety disorder involves excessive, difficult-to-control worry about multiple domains on more days than not for at least six months, with distress or functional impairment. Adults need at least three associated symptoms: restlessness, fatigue, impaired concentration, irritability, muscle tension, or sleep disturbance. Assess medical, medication, and substance contributors and competing psychiatric explanations. CBT and an appropriately selected SSRI or SNRI are established treatments. These medicines take weeks to work; benzodiazepine dependence limits their role in ongoing treatment. See [NIMH guidance on generalized anxiety disorder](https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad).
Apply it
A patient has eight months of uncontrollable worry about health, finances, and relatives, with muscle tension, poor sleep, fatigue, and avoidance of activities. Assess contributors and offer CBT or an individualized medication plan rather than treating each reassurance-seeking visit as an isolated concern.
Common pitfall: Anxiety caused by an acute medical problem or withdrawal requires cause-directed treatment. Short-lived situational worry does not meet the duration requirement, and repeated sedative prescriptions can create dependence.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
33.How should alcohol and sedative use change the assessment of falls, anxiety, or confusion?
Ask directly about alcohol quantity and timing, nonprescription products, benzodiazepines, consequences, and prior withdrawal. Alcohol-related harm and sedative dependence can present through falls, sleep problems, anxiety, or cognitive change. Physiological dependence alone does not establish a substance use disorder. Abrupt cessation can produce dangerous withdrawal, including seizures; benzodiazepine withdrawal requires an individualized supervised taper. Older adults with alcohol dependence need assessment for medically supervised withdrawal, especially with medical complexity or prior complicated withdrawal. Withdrawal management should lead into continuing addiction treatment. See [SAMHSA TIP 26](https://library.samhsa.gov/sites/default/files/tip-26-pep20-02-01-011.pdf).
Apply it
A patient admitted after a fall drinks heavily each day and regularly takes a benzodiazepine. Establish the last doses and withdrawal history, monitor closely, and arrange an appropriate supervised plan rather than stopping both without assessment.
Common pitfall: Do not dismiss substance-related harm because the patient is retired or lives alone. Conversely, tolerance or withdrawal during appropriate prescribed treatment does not by itself establish compulsive misuse.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
34.When do suicidal thoughts require an immediate safety response?
Assess current thoughts, frequency, plan, access to means, previous behavior, symptoms, stressors, and supports. Current suicidal thoughts require urgent evaluation; imminent risk requires emergency psychiatric assessment with the patient kept safe and not left alone. A specific near-term plan, available means, and expressed intent are decisive. The first decision is a safe disposition, followed by appropriate treatment.
Apply it
A patient reports intending to take a stockpile of tablets that evening. Keep the patient under direct supervision and arrange emergency psychiatric evaluation, including a safe transfer rather than unsupervised travel.
Common pitfall: Protective relationships or a promise to seek help do not neutralize current intent. Starting an antidepressant or arranging routine follow-up cannot substitute for immediate safety.
35.How does a safety plan differ from a safety contract?
A safety plan identifies warning signs, coping strategies, supportive contacts, professional resources, and steps to reduce access to lethal means. A safety contract asks for a promise not to act and does not substitute for assessment or planning. The plan should be collaborative and usable during distress. It complements an appropriate disposition rather than making an imminently unsafe outpatient situation suitable for routine discharge.
Apply it
After evaluation determines that emergency admission is unnecessary, identify warning signs, trusted contacts, crisis resources, and arrangements for securing medicines. Check that the patient can explain how to use the plan.
Common pitfall: A signed promise can create false reassurance. A detailed plan also does not replace emergency care when risk is imminent.
Geriatric Syndromes22.5%
36.How should acute fluctuating inattention, including quiet withdrawal, be evaluated?
Delirium develops over a short interval with disturbed attention and awareness and a fluctuating course. Hypoactive delirium may appear as sleepiness, slowed responses, or withdrawal without agitation. Compare attention and alertness with baseline using collateral history; delirium can coexist with dementia. Investigate immediate physiological threats and plausible interacting causes such as illness, medication effects, dehydration, pain, and environmental disruption. Follow the clinical history and examination rather than allowing an incidental abnormal test to end the assessment.
Apply it
A resident with stable memory impairment becomes sleepy and unable to follow conversation over one day after poor intake and a sedating medicine. Assess hypoactive delirium, establish a medication and illness timeline, and address contributors.
Common pitfall: Being quiet does not indicate improvement. Dementia does not explain abrupt fluctuating inattention by itself, and finding one precipitant does not exclude additional causes.
National Library of Medicine: Delirium · American Geriatrics Society: Basic Facts about Delirium
37.How do tissue findings determine pressure-injury classification and immediate care?
Stage 1 is intact skin with localized nonblanchable erythema. Stage 2 is partial-thickness skin loss with exposed dermis; adipose, slough, and eschar are absent. Stage 3 is full-thickness skin loss with visible adipose but without exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone. Stage 4 is full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone. Subcutaneous fat alone does not establish stage 4. An unstageable pressure injury has full-thickness skin and tissue loss whose extent is obscured by slough or eschar. Persistent nonblanchable maroon or purple discoloration can indicate deep tissue pressure injury, including beneath intact skin. Relieve pressure promptly through offloading, individualized repositioning, and appropriate support surfaces; address moisture and nutritional needs. See [AHRQ staging guidance](https://www.ahrq.gov/patient-safety/settings/hospital/resource/pressureinjury/workshop/guide5.html) and the [pressure-injury prevention guideline](https://www.minsal.cl/wp-content/uploads/2026/02/Pressure-Injury-Mgmt_WEB_2025-Update_FINAL.pdf).
Apply it
An immobile patient with intact, persistently nonblanching sacral erythema has stage 1 injury and needs immediate pressure relief and reassessment. A separate sacral wound with full-thickness skin loss, visible fat, and no exposed or directly palpable qualifying deeper structures is stage 3. Exposed tendon would establish stage 4. If eschar obscures the extent of full-thickness tissue loss, classify the injury as unstageable rather than estimating its stage from its surface appearance.
Common pitfall: A shallow wound containing slough is not stage 2. Slough can occur in stage 3 or stage 4 injuries; the unstageable category applies when slough or eschar obscures the extent of tissue loss. Wound depth in centimeters alone does not distinguish stage 3 from stage 4: the tissue structures involved are decisive. Incontinence-associated dermatitis and skin tears should not receive pressure-injury stages merely because they involve superficial skin loss.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
38.What should suspected elder mistreatment trigger?
Mistreatment includes physical or emotional abuse, neglect, and financial exploitation. Speak with the patient privately, assess injuries and immediate safety, and explore access to food, medicines, money, and assistance. Document observed findings and the patient's account, assess relevant decision-making capacity, and involve protective resources under applicable reporting law and policy. Suspicion can justify a report; clinicians do not need to prove abuse before seeking protective investigation. Immediate danger requires emergency protection. See [National Institute on Aging guidance](https://www.nia.nih.gov/health/elder-abuse/elder-abuse).
Apply it
A dependent patient has unexplained injuries, missed medicines, and fear when a caregiver answers every question. Arrange a private conversation, treat urgent problems, document findings, and develop a safe disposition with appropriate protective services.
Common pitfall: Do not confront a suspected perpetrator in a way that increases danger or assume that family involvement guarantees safety. A diagnosis of dementia does not automatically eliminate the patient's ability to describe events or participate in decisions.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026 · AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
39.Which supportive measures help a patient with delirium?
Combine treatment of underlying causes with familiar communication, orientation cues, glasses and hearing aids, suitable hydration and nutrition, sleep support, and safe activity. Sensory and functional needs remain important during medical investigation. Individualize support and reassess it because environmental measures alone cannot correct untreated illness, medication toxicity, or an unmet physiological need.
Apply it
A patient lacks hearing aids, sleeps through daylight hours, and cannot reach a drink. Restore sensory aids, accessible fluids, orientation, and an appropriate day-night routine while treating acute contributors and supporting safe mobility.
Common pitfall: Supportive measures complement cause-directed treatment. Repeated correction without addressing hearing, comfort, or environmental needs may increase distress and make communication less effective.
National Library of Medicine: Delirium · American Geriatrics Society: Basic Facts about Delirium
40.How does functional independence distinguish mild cognitive impairment from dementia?
Mild cognitive impairment involves cognitive decline with substantially preserved independence, although tasks may require more effort or compensatory strategies. Dementia requires cognitive decline that interferes with usual activities and independent functioning. Establish whether errors in finances, medicines, or shopping are caused by cognition rather than vision, mobility, opportunity, or longstanding household roles. A cognitive score alone cannot establish this distinction.
Apply it
One patient manages bills independently using reminders; another requires supervision because cognitive errors cause unpaid bills and duplicate medicine doses. Determine whether independence is preserved before assigning the same classification.
Common pitfall: Receiving help does not prove cognitive dependence when physical barriers explain it. Preserved basic self-care also does not establish intact instrumental independence.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026 · Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility
41.Which findings support dementia with Lewy bodies?
First establish dementia: progressive cognitive decline must interfere with usual activities or independence. Core Lewy body features include marked cognitive fluctuations, recurrent well-formed visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism. With established dementia, two or more core features support probable dementia with Lewy bodies. Memory loss need not dominate early; attention, executive, and visuoperceptual difficulties may be conspicuous.
Apply it
A patient can no longer manage medicines or finances because of cognitive decline and has recurrent detailed visual hallucinations, variable alertness, dream enactment, and slowed movement. Functional decline and multiple core features support the diagnosis.
Common pitfall: Hallucinations alone do not establish dementia. A new acute deterioration still requires evaluation for delirium even when chronic Lewy body features are present.
NHS: Dementia with Lewy bodies — Symptoms · National Library of Medicine: Delirium
42.How do common dementia patterns differ?
Typical Alzheimer disease begins with insidious progressive difficulty learning and retaining new information. Vascular cognitive impairment is suggested by a relationship to cerebrovascular events, focal findings, or prominent executive and processing-speed deficits; its course is not always stepwise. Behavioral-variant frontotemporal dementia features early disinhibition, apathy, loss of empathy, compulsive behavior, or altered eating, while language variants begin with progressive language dysfunction. Lewy body disease combines its characteristic cognitive, perceptual, sleep, and motor features.
Apply it
Early loss of social restraint and empathy with relatively less prominent initial memory difficulty favors a frontotemporal pattern over typical amnestic Alzheimer disease. Multiple vascular events and executive slowing suggest a vascular contribution.
Common pitfall: These are patterns rather than exclusive checklists. Mixed pathology is common, and every dementia diagnosis still requires functional interference from cognitive decline.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026 · NHS: Dementia with Lewy bodies — Symptoms
43.What does an effective fall-risk screen ask?
CDC STEADI asks about falls in the past year, unsteadiness when standing or walking, and worry about falling. A positive response calls for further assessment rather than supplying a diagnosis. Patients may reduce their exposure by limiting activity, so asking only about injuries or counting past falls can miss current instability and fear-related functional restriction.
Apply it
An older adult denies falls but holds furniture while walking and avoids the garden because of fear. Assess gait, balance, strength, medicines, and other contributors despite the absence of a reported fall.
Common pitfall: An apparently reassuring fall count can reflect restricted activity. A positive screen identifies a need for assessment; it does not mean every patient requires the same device or exercise plan.
CDC STEADI Algorithm for Fall Risk Screening, Assessment, and Intervention
44.How should fall-prevention interventions be individualized?
Assess gait, balance, strength, medication effects, vision, feet and footwear, orthostatic pressure, and environmental hazards. Match interventions to findings: balance exercise addresses instability, medication adjustment addresses a contributory exposure, and environmental changes address obstacles. Follow-up should determine whether the patient can implement the plan and whether symptoms, mobility, and falls improve.
Apply it
A patient falls while rising at night and has poor balance, loose slippers, and postural symptoms. Address footwear, balance training, safe lighting and access, and the postural response rather than only advising greater caution.
Common pitfall: An assistive device may leave medication, vision, or postural contributors untreated. Generic advice cannot substitute for correcting the specific abnormalities demonstrated during assessment.
CDC STEADI Algorithm for Fall Risk Screening, Assessment, and Intervention
45.How does bladder training address urgency incontinence?
Urgency incontinence is leakage associated with a sudden compelling desire to void. Bladder training uses planned voiding and gradual adjustment of intervals; urgency-suppression techniques help manage an urge without rushing. Pelvic floor training may contribute. A behavioral plan requires understanding, practice, accessible toileting, and reassessment of the patient's ability to follow the schedule.
Apply it
A patient leaks after sudden urges and rushes unsafely to the toilet. Develop bladder training and urgency-suppression skills while improving safe toilet access. Review the timing of episodes to distinguish urgency from stress leakage or access barriers.
Common pitfall: Urgency-associated leakage differs from leakage during coughing or lifting. Behavioral recommendations must be feasible for cognition, mobility, and available assistance rather than imposed as an unsupported schedule.
46.Why are pelvic floor exercises useful for stress incontinence?
Stress incontinence produces leakage during increases in abdominal pressure, such as coughing, sneezing, or exertion. Pelvic floor exercises strengthen supporting muscles and improve their effective use. Correct identification of the muscles and consistent practice matter. Stress and urgency symptoms may coexist, so assess triggers and reassess the full symptom pattern rather than selecting treatment from one episode.
Apply it
A patient has small leaks with coughing and lifting without a preceding compelling urge. Teach pelvic floor exercises, confirm that the intended muscles contract, and follow leakage and activity-related goals over time.
Common pitfall: Stress refers to mechanical pressure rather than emotional anxiety. A characteristic stress trigger does not exclude a concurrent urgency mechanism or an additional toileting-access problem.
47.When is urinary leakage primarily a toileting-access problem?
Continence requires recognizing the need to void, reaching a toilet, managing clothing, and obtaining assistance when needed. Mobility, cognition, dexterity, and environmental barriers can cause leakage even when bladder storage is not the dominant problem. Reconstruct the sequence leading to episodes and target the actual failure point with access changes, clothing adaptations, assistance, or planned toileting.
Apply it
A patient recognizes the need but cannot release tight clothing or reach a distant bathroom in time. Adapt clothing and the environment, arrange timely assistance, and reassess whether episodes decrease.
Common pitfall: Functional barriers can coexist with urgency or other urinary disease. Improving access does not remove the need to assess remaining symptoms or new urinary and systemic findings.
NIDDK: Treatments for Bladder Control Problems · Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility
48.How is frailty different from age, comorbidity, or established disability?
Frailty is reduced physiological reserve and increased vulnerability to stressors. One commonly used physical phenotype assesses unintentional weight loss, exhaustion, weakness, slow walking, and low activity: three or more indicate frailty, while one or two indicate prefrailty. Frailty overlaps with multimorbidity and disability but is not identical to either. Assess nutrition, strength, mobility, medicines, and reversible contributors, then match exercise and support to capability.
Apply it
An independent older adult has weight loss, exhaustion, weak grip, and slow gait. Recognize frailty despite preserved basic self-care and address nutritional and physical deficits before an acute stressor produces dependence.
Common pitfall: Chronological age alone does not diagnose frailty. Several validated approaches exist, and criteria from different tools should not be mixed into an unvalidated score.
49.How can medication review connect falls and cognitive change?
Medication effects can cause altered attention, sedation, postural symptoms, and impaired mobility. Establish actual exposure, including nonprescription products, and compare symptom onset with additions, dose changes, or discontinuations. Identify plausible contributors while preserving indicated treatment where possible. Clarify timing and discrepancies rather than relying solely on the chart list, which may differ from what the patient actually takes.
Apply it
Morning unsteadiness and daytime confusion begin after a nonprescription sleep product is added. Verify ingredients and actual use, examine the temporal relationship, and reassess the regimen alongside other acute causes.
Common pitfall: Timing is a clue rather than proof. Reviewing only prescribed medicines can miss products or discrepancies that materially change both cognitive and fall-risk assessment.
CDC STEADI Algorithm for Fall Risk Screening, Assessment, and Intervention · National Library of Medicine: Delirium · AHRQ MATCH Toolkit, Chapter 3: Designing the Medication Reconciliation Process
Functional Assessment and Rehabilitation3%
50.How do basic and instrumental activities reveal different support needs?
Basic activities include bathing, dressing, toileting, transferring, continence, and feeding. Instrumental activities include medicines, finances, shopping, and transportation. Assess actual performance, assistance, equipment, and reasons for difficulty. A patient may manage every basic activity yet need substantial community-living support because instrumental tasks are impaired. Identify whether the limitation reflects cognition, physical ability, sensory loss, or the environment.
Apply it
A patient independently performs all basic activities, including continence, but a daughter manages medicines and bills after repeated errors. Document preserved basic ADLs and impaired instrumental independence, then specify the necessary help.
Common pitfall: Do not infer continence from a general self-care statement. Distinguish inability from never having performed a customary household task, and record assistance that makes apparent independence possible.
Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility
51.How should baseline function, treatment tolerance, and support determine rehabilitation setting?
Compare preillness and current function, define meaningful goals, and assess medical stability, therapy tolerance, cognition, equipment, home barriers, and help. Inpatient rehabilitation suits patients needing an intensive coordinated program with continued physician supervision. Skilled nursing rehabilitation may suit those needing daily skilled nursing or therapy with a less intensive rehabilitation schedule. Home rehabilitation requires safe arrangements between visits; Medicare home health generally requires homebound status and qualifying intermittent skilled needs. Outpatient therapy requires feasible travel. See [Medicare inpatient rehabilitation guidance](https://www.medicare.gov/coverage/inpatient-rehabilitation-care) and [home health guidance](https://www.medicare.gov/coverage/home-health-services).
Apply it
After stroke, a medically stable patient who can participate in intensive multidisciplinary therapy may suit inpatient rehabilitation. A patient unable to tolerate that intensity and needing daily skilled assistance may need a skilled nursing setting. Check transfers, stairs, toileting, and caregiver availability before recommending home.
Common pitfall: Walking along a level ward corridor does not establish home readiness. Intermittent home health visits do not provide continuous supervision or replace hands-on assistance between visits.
Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility · Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
Caring for Elderly Patients16%
52.What makes decision-making capacity specific to a clinical choice?
Assess understanding of relevant information, appreciation of its personal implications, reasoning about options, and communication of a choice. Evaluate these abilities for the decision at hand after addressing reversible barriers. Dementia or an unusual preference does not independently establish incapacity. Connect the patient's explanation to the proposed intervention and consequences rather than relying solely on a cognitive score.
Apply it
A patient with mild dementia declines a procedure while explaining its purpose, alternatives, and personal consequences. Assess reasoning and voluntariness instead of automatically transferring authority to a surrogate.
Common pitfall: Disagreement does not demonstrate incapacity. Stating a preference alone also does not establish understanding or appreciation, and hearing or language barriers must be addressed before judging ability.
AMA Code of Medical Ethics: Informed Consent · AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
53.How should life expectancy and treatment intent shape screening?
Screening seeks disease before symptoms and can impose immediate burdens while benefits may take years to emerge. Consider prior screening, baseline risk, health status, life expectancy, patient preferences, and willingness to undergo diagnostic work-up and treatment. Severe illness or advanced dependence may reduce the chance of benefiting from a screening program. Evaluation of a new symptom is a separate diagnostic decision and should not be dismissed by a decision to stop routine screening.
Apply it
A patient with advanced illness would decline invasive testing and cancer treatment. Discuss whether routine screening can achieve a meaningful goal. New bleeding still warrants a goal-concordant diagnostic assessment.
Common pitfall: A birthday alone does not settle every screening decision. Stopping screening does not mean ignoring symptoms or discontinuing all preventive care.
13. Older Adults: Standards of Care in Diabetes—2026 · Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
54.When should a surrogate use substituted judgment or best interests?
When capacity is lacking, substituted judgment uses the patient's known preferences, values, prior statements, and life narrative to approximate the choice the patient would make. If preferences cannot reasonably be established, use best interests: expected benefit, suffering, treatment burdens, resulting impairments, and quality of life as experienced by the patient. Involve the patient to the extent possible. Surrogate authority and formal procedures depend on applicable law and policy.
Apply it
A patient previously prioritized interaction over burdensome life prolongation. Help the surrogate apply those values. If no meaningful preference evidence exists, compare patient-centered benefits and burdens without inventing a preference.
Common pitfall: Family preference is not automatically the patient's preference. Best interests also do not mean maximizing survival regardless of suffering or judging social worth.
AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity · 2.1.2_1.pdf
55.Which pneumococcal and RSV vaccine decisions follow age, risk, and prior-product history?
For adults at least 50 with unknown pneumococcal history or no prior conjugate vaccine, give PCV20 or PCV21 alone, or PCV15 followed by PPSV23 ordinarily at least one year later. An eight-week minimum may be used with an immunocompromising condition, cochlear implant, or CSF leak. Recovered records change the sequence: PCV13 alone calls for PCV20 or PCV21 at least one year later; PPSV23 alone permits PCV15, PCV20, or PCV21 at least one year later, without another PPSV23 after PCV15. After PCV20 or PCV21, no additional pneumococcal dose is recommended. See [CDC adult schedule notes](https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-notes.html). RSV vaccination is one dose for all adults at least 75 and adults 50–74 at increased risk, such as heart failure, COPD, or nursing-home residence; routine annual revaccination is not recommended. See [CDC RSV guidance](https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html).
Apply it
A 78-year-old with unknown pneumococcal history can receive PCV20 alone. If records instead show PCV15 nine months ago without a shorter-interval indication, schedule PPSV23 at the one-year interval. Check RSV history before offering its single dose.
Common pitfall: An unspecified previous pneumococcal injection does not establish completion. Influenza vaccination is annual, whereas RSV vaccination currently is not. Product identity and dates determine whether additional pneumococcal doses are needed.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
56.Why is careful hand feeding recommended in advanced dementia?
AGS recommends careful hand feeding when eating difficulties arise in advanced dementia. It is as good as tube feeding for death, aspiration pneumonia, functional status, and comfort. Tube feeding is associated with agitation, restraint use, tube complications, and new pressure ulcers. Discuss realistic outcomes and the patient's goals; a tube is a medical treatment that may be accepted or declined through an informed decision.
Apply it
A surrogate requests a tube to prevent aspiration in advanced dementia. Explain the outcome evidence and burdens, offer assisted feeding, and apply the patient's known values to the decision.
Common pitfall: Declining a tube does not mean declining feeding assistance or comfort care. Do not apply this recommendation automatically to every reversible swallowing disorder.
American Geriatrics Society Feeding Tubes in Advanced Dementia Position Statement — publisher full text, 2014 · AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
57.How should symptom-focused care address painful vertebral fractures?
Assess pain at rest and with movement, its effect on sleep and function, and the patient's desired activities. Combine appropriate analgesia with positioning, safe movement, and rehabilitation support. Select medication according to severity and comorbidity: NSAIDs add renal and gastrointestinal risks, while opioids may be needed for severe pain but require monitoring for sedation, delirium, constipation, and falls. Reassess relief and adverse effects together rather than equating reduced activity with comfort.
Apply it
A frail patient with a vertebral fracture cannot sleep or transfer because of pain. Provide an individualized analgesic plan and practical movement support, then check whether transfers improve without excessive sedation or constipation.
Common pitfall: Untreated pain can worsen immobility and distress. Sedation without meaningful relief is not a successful palliative outcome, and analgesia does not replace evaluation of new neurologic deficits.
The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022 · Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
58.What makes medication reconciliation and transition communication more than list copying?
Establish actual medication use, compare it with intended orders, identify discrepancies, and resolve unexplained differences. Verification may require the patient, caregiver, pharmacy, and previous records. Communicate what continues, starts, changes, or stops and explain relevant replacements or temporary treatments. The patient and receiving team need the same actionable regimen, with responsibility assigned for unresolved follow-up. Forwarding conflicting historical lists does not complete reconciliation.
Apply it
A discharge list contains an old antihypertensive and its replacement without explanation. Clarify intent with the prescribing team, correct the list, and communicate the verified instructions to the patient and receiving clinician.
Common pitfall: Automatically merging entries can duplicate treatment or restart an intentionally stopped drug. Entry dates do not prove prescribing intent, and monitoring later does not replace clarifying an available prescriber's instructions now.
AHRQ MATCH Toolkit, Chapter 3: Designing the Medication Reconciliation Process
59.Which principles determine Medicare hospice eligibility and continuing coverage?
The Medicare hospice benefit requires Part A eligibility, physician certification of a prognosis of six months or less if the illness follows its normal course, and election of hospice care for the terminal illness and related conditions. The focus is palliation rather than curative treatment for those conditions. Benefits include two 90-day periods followed by unlimited 60-day periods when eligibility is recertified; living beyond six months does not automatically end coverage. Hospice arranges terminal-illness care. Routine room and board and continuous custodial help are not generally covered. See [CMS hospice principles](https://www.cms.gov/medicare/payment/fee-for-service-providers/hospice) and [Medicare hospice coverage](https://www.medicare.gov/coverage/hospice-care).
Apply it
A patient with advanced heart failure elects comfort-focused care and has a certified prognosis of six months or less. Discuss hospice services, arrange symptom management, and identify who will provide daily assistance at home. Reassess eligibility at recertification rather than treating six months as a fixed deadline.
Common pitfall: Hospice is not restricted to cancer or the final days of life. Election does not forfeit coverage for unrelated conditions, and a patient may revoke hospice. Hospice enrollment alone does not supply a round-the-clock caregiver.
Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
60.How can functional assessment make a caregiving plan realistic?
Match specific tasks to abilities, environmental adaptations, and actual assistance. Establish who can help, when help is needed, and whether the arrangement is sustainable. General statements that family will manage can conceal medication, feeding, transfer, or toileting gaps. Involve the patient while identifying support needs before discharge, and distinguish occasional checking from assistance that must occur at a particular time.
Apply it
A patient needs help with midday medicines and transfers while relatives are at work. Map task timing and arrange additional assistance or adaptations before declaring the home plan complete.
Common pitfall: A nearby relative is not necessarily available. Equipment and written instructions do not replace hands-on assistance when the patient cannot safely perform a task.
Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility · AHRQ MATCH Toolkit, Chapter 3: Designing the Medication Reconciliation Process
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the complete official outline as the master scope, with the largest study block devoted to Diseases in the Elderly.
- Distinguish cardiovascular, cerebrovascular, renal, gastrointestinal, hematologic, endocrine, infectious, pulmonary, and musculoskeletal mechanisms before selecting treatment.
- Learn actionable criteria and regimens: orthostatic changes, oxygen eligibility, depressive symptom persistence, C. difficile severity and treatment, and vaccine sequences.
- Use baseline function and time course to distinguish delirium, chronic cognitive disorders, frailty, anxiety, substance-related problems, and new disability.
- Match treatment to physiology and practical ability, including kidney function, valve disease, hypoglycemia, drug discontinuation, mobility, skin integrity, and toileting access.
- Connect rehabilitation setting, protection from mistreatment, prevention, surrogate reasoning, hospice, assisted feeding, and care transitions to specific patient needs and goals.
A practical preparation plan
1. Map the complete outline
Use the August 2026 certification blueprint as the master checklist. Mark these concepts as selected coverage and schedule additional study for topics beyond them. Domain counts support planning without establishing complete preparation.
2. Build discriminating comparisons
For each topic, identify the finding that changes the decision: acute inattention, cognitive loss of independence, stroke mechanism, mucosal trauma, a qualifying fracture, moderate mitral stenosis, recurrent hypoglycemia, or a qualifying oxygen measurement.
3. Practise a structured geriatric case
Establish baseline function, time course, physiological threats, actual medicines and substances, cognition, mobility, skin integrity, safety, support, and goals. Select the diagnosis, test, treatment, or setting that addresses the demonstrated problem.
4. Calculate and classify
Rehearse absolute risk reduction and time-specific numbers needed to treat. Practise orthostatic and oxygen thresholds, depressive symptom frequency, C. difficile severity and regimens, vaccine sequences, and the ADA health-status framework.
5. Use the questions diagnostically
Answer each question before reading its explanation. For every error, explain why the selected approach was attractive and which case detail made another option better. Use the flashcards later for spaced recall.
6. Rehearse communication and transitions
Practise explaining anticoagulation, insulin simplification, screening, assisted feeding, hospice, and surrogate reasoning. Finish each simulated discharge with a verified medication plan, an appropriate rehabilitation setting, and a task-specific account of needed help.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Geriatric Medicine Blueprint — Certification Examination (CERT), August 2026
- ABIM Blueprints
- Register, Prepare and Take Your Subspecialty Certification Exam — Geriatric Medicine
- ABIM Geriatric Medicine Certification Policies
- ABIM Expanded Blueprints
- Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
- CDC STEADI: Measuring Orthostatic Blood Pressure
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
- The clinician’s guide to prevention and treatment of osteoporosis — BHOF, 2022
- ADA: Insulin Deintensification in Type 2 Diabetes
- ADA Standards of Care in Diabetes
- IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria
- SHEA/IDSA 2017 Clinical Practice Guideline Update for Clostridium difficile Infection
- SHEA/IDSA 2021 Focused Update for Clostridioides difficile Infection
- 2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
- Home Oxygen Therapy for Adults with Chronic Lung Disease — Official ATS Guideline, 2020
- National Eye Institute: Age-Related Macular Degeneration
- National Institute of Mental Health: Depression
- NIMH Adult Outpatient Brief Suicide Safety Assessment Guide
- National Library of Medicine: Delirium
- American Geriatrics Society: Basic Facts about Delirium
- NHS: Dementia with Lewy bodies — Symptoms
- CDC STEADI Algorithm for Fall Risk Screening, Assessment, and Intervention
- NIDDK: Treatments for Bladder Control Problems
- Hartford Institute for Geriatric Nursing: Assessing Function and Promoting Mobility
- AMA Code of Medical Ethics: Informed Consent
- AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
- American Geriatrics Society feeding tubes in advanced dementia position statement, 2014
- AHRQ MATCH Toolkit for Medication Reconciliation
- The clinician’s guide to prevention and treatment of osteoporosis — publisher full text, 2022
- 13. Older Adults: Standards of Care in Diabetes—2026
- American Geriatrics Society Feeding Tubes in Advanced Dementia Position Statement — publisher full text, 2014
- AHRQ MATCH Toolkit, Chapter 3: Designing the Medication Reconciliation Process
- Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline - PMC
- 2.1.2_1.pdf
- osteoarthritis-guideline-2019.pdf
- Frailty in older adults: evidence for a phenotype - PubMed
- FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) | FDA
- KDIGO-2024-CKD-Guideline.pdf
- Generalized Anxiety Disorder: What You Need to Know - National Institute of Mental Health (NIMH)
- Inpatient Rehabilitation Care Coverage
- Home Health Services Coverage
- Hospice | CMS
- Hospice Care Coverage
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.